Company Filing History:
2 out of 272 
1 out of 2 
1 out of 47 
Years Active: 2007-2010
Title: Philippe Collas: Innovator in Biotechnology
Introduction
Philippe Collas is a prominent inventor based in Oslo, Norway. He has made significant contributions to the field of biotechnology, particularly in the development of methods for producing human antibodies and altering cell fate. With a total of 4 patents to his name, Collas has established himself as a key figure in innovative research.
Latest Patents
One of his latest patents is titled "Transgenic ungulates capable of human antibody production." This invention features novel methods for producing large quantities of xenogenous antibodies, such as human antibodies. The process involves the inactivation of IgM heavy chain expression and, optionally, the inactivation of Ig light chain expression. Additionally, it includes the introduction of an artificial chromosome that facilitates the expression of xenogenous antibodies, preferably human antibodies. Another significant patent is "Methods for altering cell fate," which provides techniques for changing the expression profile of a cell to convert it from one cell type to a desired cell type. These reprogrammed cells have potential applications in treating mammals in need of specific cell types.
Career Highlights
Throughout his career, Philippe Collas has worked with notable companies in the biotechnology sector, including Kyowa Hakko Kirin Co., Limited and Aurox, LLC. His work has focused on advancing the understanding and application of genetic engineering and cell reprogramming.
Collaborations
Collas has collaborated with esteemed colleagues in the field, including James M. Robl and Eddie Sullivan. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Philippe Collas is a distinguished inventor whose work in biotechnology has led to groundbreaking advancements in antibody production and cell reprogramming. His contributions continue to influence the field and pave the way for future innovations.